Recent Press Releases

January 9, 2025

Frontier Medicines Announces FMC-220, the First Covalent p53 Y220C Activator Development Candidate, with Best-in-Class Potential

January 8, 2025

Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference

July 23, 2024

Frontier Medicines Announces Milestone Payment in AbbVie Partnership, Following Advancement of Lead Candidates Targeting a Historically Undruggable Transcription Factor


Events & Presentations
UPCOMING EVENTS

There are currently no upcoming events scheduled


Select Media Coverage

April 11, 2024

Fierce Biotech: AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data

February 22, 2024

Fierce Biotech: Frontier CEO weathers 'one of the hardest financings' of his career to close $80M series C

February 22, 2024

San Francisco Business Times: Peninsula biotech raises $80M as it doses 1st person in 1st clinical trial

Media Center
Media Contact

Contact PR Team

Logos
Click on the links below to download a high resolution image of the Frontier Medicines logo